These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sipple syndrome with lichen amyloidosis as a paracrinopathy: pleiotropy, heterogeneity, or a contiguous gene? Kousseff BG, Espinoza C, Zamore GA. J Am Acad Dermatol; 1991 Oct 29; 25(4):651-7. PubMed ID: 1686438 [Abstract] [Full Text] [Related]
6. Surgical management of MEN-1 and -2: state of the art. Akerström G, Stålberg P. Surg Clin North Am; 2009 Oct 29; 89(5):1047-68. PubMed ID: 19836484 [Abstract] [Full Text] [Related]
8. Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant. Donovan DT, Levy ML, Furst EJ, Alford BR, Wheeler T, Tschen JA, Gagel RF. Henry Ford Hosp Med J; 1989 Oct 29; 37(3-4):147-50. PubMed ID: 2576950 [Abstract] [Full Text] [Related]
13. [Multiple endocrine neoplasm syndrome (MEN-2a) or Sipple syndrome. Report of 2 cases]. Sánchez Román J, Morales Méndez S, Conde García J, Vaquero Ruiz F. Rev Clin Esp; 1995 Jan 29; 170(1-2):45-9. PubMed ID: 6138823 [No Abstract] [Full Text] [Related]
14. Bilateral pheochromocytoma during the postpartum period. Wattanachanya L, Bunworasate U, Plengpanich W, Houngngam N, Buranasupkajorn P, Sunthornyothin S, Shotelersuk V, Snabboon T. Arch Gynecol Obstet; 2009 Dec 29; 280(6):1055-8. PubMed ID: 19340440 [Abstract] [Full Text] [Related]
15. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP. Endocr Relat Cancer; 2008 Dec 29; 15(4):1035-41. PubMed ID: 18794325 [Abstract] [Full Text] [Related]
18. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW. Clin Endocrinol (Oxf); 2005 Dec 29; 63(6):676-82. PubMed ID: 16343103 [Abstract] [Full Text] [Related]